Summary: Guidance Document- Post-Notice of Compliance (NOC) Changes: Safety and Efficacy
Données et ressources
Info additionnelle
| Champ | Valeur |
|---|---|
| Source | |
| Version | |
| Producteur | |
| Courriel de l'auteur | |
| Mainteneur | |
| Courriel du mainteneur | |
| Data Level | |
| Agreement Required | |
| Purpose Constraints | |
| Redistribution Allowed | |
| AI Training Allowed | |
| Data Steward | |
| Title (French) | Sommaire : Ligne directrice - Changements survenus après l'avis de conformité (AC) : Document sur l’innocuité et efficacité |
| Update Frequency | as_needed |
| Geographic Scope | [] |
| Criticality Level | [] |
| Sensitivity Level | unrestricted |
| Langue | |
| Contact Person | |
| Contact Email | |
| Dictionnaire de données | |
| Open Canada Date Published | 2021-05-26 00:00:00 |
| Open Canada Date Modified | |
| Open Canada Subject | ["health_and_safety"] |
| Open Canada Keywords | {"fr": ["document d'orientation", "sommaire", "modifications post-avis de conformité", "innocuité et efficacité", "cadre", "innocuité et efficacité", "sur la qualité", "aux nouveaux", "médicaments"], "en": ["summary guidance document", "post-notice of-compliance-changes", "safety-and-efficacy", "framework", "safety-and-efficacy", "quality guidance documents", "post-approval changes to-new-drugs"]} |
| Open Canada Collection | publication |
| Principal Organization | |
| Reference Data | |
| Official Source |